Evidence map›Paper›PMID 37502360›Full record

ArticleFrontiers in medicine2023

Moderate hypoxia induces metabolic divergence in circulating monocytes and tissue resident macrophages from Berkeley sickle cell anemia mice.

Christina Lisk, Francesca Cendali, David I Pak, Delaney Swindle, Kathryn Hassell, Rachelle Nuss, Gemlyn George, Pavel Davizon-Castillo, Paul W Buehler, Angelo D'Alessandro and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Christina LiskCardiovascular and Pulmonary Research Laboratory, Department of Medicine, University of Colorado Denver-Anschutz Medical Campus, Aurora, CO, United States.
Francesca CendaliDepartment of Biochemistry and Molecular Genetics, Graduate School, University of Colorado, Anschutz, Medical Campus, Aurora, CO, United States.
David I PakCardiovascular and Pulmonary Research Laboratory, Department of Medicine, University of Colorado Denver-Anschutz Medical Campus, Aurora, CO, United States.
Delaney SwindleCardiovascular and Pulmonary Research Laboratory, Department of Medicine, University of Colorado Denver-Anschutz Medical Campus, Aurora, CO, United States.
Kathryn HassellDivision of Hematology Colorado Sickle Cell Treatment and Research Center, School of Medicine, Anschutz Medical Campus, University of Colorado-Denver School of Medicine, Aurora, CO, United States.
Rachelle NussDivision of Hematology Colorado Sickle Cell Treatment and Research Center, School of Medicine, Anschutz Medical Campus, University of Colorado-Denver School of Medicine, Aurora, CO, United States.
Gemlyn GeorgeDivision of Hematology Colorado Sickle Cell Treatment and Research Center, School of Medicine, Anschutz Medical Campus, University of Colorado-Denver School of Medicine, Aurora, CO, United States.
Pavel Davizon-CastilloDepartment of Pediatrics, Hemophilia and Thrombosis Center, University of Colorado Anschutz, Medical Campus, Aurora, CO, United States.
Paul W BuehlerThe Center for Blood Oxygen Transport, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, United States.
Angelo D'AlessandroDepartment of Biochemistry and Molecular Genetics, Graduate School, University of Colorado, Anschutz, Medical Campus, Aurora, CO, United States.
David C IrwinCardiovascular and Pulmonary Research Laboratory, Department of Medicine, University of Colorado Denver-Anschutz Medical Campus, Aurora, CO, United States.
University of Colorado Denver · USUniversity of Colorado Anschutz Medical Campus · USUniversity of Maryland, Baltimore · US

Funding

VRAC and Rho in pulmonary EC proliferationP01HL014985 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI STENMARK, KURT R. · 1985 to 2019
$35.1M
Translational Pulmonary Vascular Biology ProgramT32HL007171 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI Sonia Castro Flores, Tim Lahm · 1985 to 2026
$9.4M
The Impact of Oxidative Stress on Erythocyte BiologyR01HL148151 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI D'ALESSANDRO, ANGELO, KARAFIN, MATTHEW S · 2019 to 2022
$8.9M
The paradoxical response to iron in pulmonary hypertension of sickle cell diseaseR01HL161004 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI BUEHLER, PAUL WERNER, D'ALESSANDRO, ANGELO · 2022 to 2025
$2.7M
Bioengineering a Dual Function Protein Construct to Detoxify Heme and HemoglobinR01HL159862 · NHLBI · OHIO STATE UNIVERSITY · PI BUEHLER, PAUL WERNER, CABRALES, PEDRO · 2021 to 2024
$2.6M
Aerosolized therapy for hemoglobin toxicity in the treatment of hemolytic diseasesR01HL158076 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI BUEHLER, PAUL WERNER, IRWIN, DAVID CHARLES · 2022 to 2025
$2.5M
The contribution of free hemoglobin in the progression of pulmonary remodelingR01HL125642 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI IRWIN, DAVID CHARLES · 2015 to 2019
$1.9M
Inflammation-mediated platelet hyperreactivity and thrombosisK99HL156058 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI DAVIZON-CASTILLO, PAVEL · 2021 to 2024
$852k
BLRD VA I01 BX002042NHLBI NIH HHS K99 HL156058NHLBI NIH HHS P01 HL014985NHLBI NIH HHS R01 HL125642NHLBI NIH HHS R01 HL148151NHLBI NIH HHS R01 HL158076NHLBI NIH HHS R01 HL159862NHLBI NIH HHS R01 HL161004NHLBI NIH HHS T32 HL007171
6 · The paper itself

Abstract

Introduction: Human and murine sickle cell disease (SCD) associated pulmonary hypertension (PH) is defined by hemolysis, nitric oxide depletion, inflammation, and thrombosis. Further, hemoglobin (Hb), heme, and iron accumulation are consistently observed in pulmonary adventitial macrophages at autopsy and in hypoxia driven rodent models of SCD, which show distribution of ferric and ferrous Hb as well as HO-1 and ferritin heavy chain. The anatomic localization of these macrophages is consistent with areas of significant vascular remodeling. However, their contributions toward progressive disease may include unique, but also common mechanisms, that overlap with idiopathic and other forms of pulmonary hypertension. These processes likely extend to the vasculature of other organs that are consistently impaired in advanced SCD. Methods: To date, limited information is available on the metabolism of macrophages or monocytes isolated from lung, spleen, and peripheral blood in humans or murine models of SCD. Results: Here we hypothesize that metabolism of macrophages and monocytes isolated from this triad of tissue differs between Berkley SCD mice exposed for ten weeks to moderate hypobaric hypoxia (simulated 8,000 ft, 15.4% O2) or normoxia (Denver altitude, 5000 ft) with normoxia exposed wild type mice evaluated as controls. Discussion: This study represents an initial set of data that describes the metabolism in monocytes and macrophages isolated from moderately hypoxic SCD mice peripheral lung, spleen, and blood mononuclear cells.

Indexed as

hypoxiametabolic diseasepulmonary hypertensionsickle cell diseasespleen

Identifiers

PMID37502360
PMCPMC10370499
OpenAlexW4384071871

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.